UNSPSC 51172403: Alginic acid/aluminum hydroxide/calcium stearate/magnesium trisilicate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA109. This VA Drug Class (GA109) classifies this compound as belonging to the group MAGNESIUM/SODIUM BICARBONATE CONTAINING ANTACIDS.

UNSPSC 51172403 Alginic acid/aluminum hydroxide/calcium stearate/magnesium trisilicate is a Commodity code that shows minimal relevant recent state and local procurement activity. The three opportunities posted in the recent-opportunities block—offender drug testing services (Collin County), a pharmacy benefit direct-to-manufacturer RFI (Texas HHS Commission), and a cooperative purchasing agreement for generic pharmaceuticals and OTC products (Minnesota Multistate Cooperative Purchasing Alliance)—do not align with the code's nominal scope of antacid and gastrointestinal active pharmaceutical ingredients. The Collin County RFP focuses on specimen collection and immunoassay testing infrastructure; the Texas HHS RFI concerns pharmacy benefit program administration and manufacturer contracting strategy; and the MMCAP RFP solicits finished generic and OTC pharmaceutical products through authorized wholesalers. None of these opportunities involves procurement of the specific chemical compounds or raw ingredients the code names.

The mismatch between the code's stated scope and the actual work being solicited suggests that this code sees little or no targeted state and local purchasing activity for alginic acid and related antacid compounds as standalone line items or raw materials. State and local buyers appear to source these materials either through broader pharmaceutical or medical-supply cooperative vehicles or through vendor-integrated finished-product agreements rather than as discrete commodity purchases. Firms pursuing opportunities under this code should verify that their target jurisdictions are actually soliciting these compounds directly before allocating business development resources.